MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 05-07-2026
EDAP TMS S.A. P/CF Ratio 2011-2026 | EDAP
Annual P/CF Ratio EDAP TMS S.A.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | -4.42 | -19.1 | -87.6 | 50.6 | 114 | 29 | 441 | -24.3 | 140 | 76.5 | -61.4 | -23.2 | -97.7 | -20.6 | -8.86 | -4.42 | - |
All numbers in EUR currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 441 | -97.7 | 31.2 |
P/CF Ratio of other stocks in the Medical devices industry
| Issuer | P/CF Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Cutera
CUTR
|
-0.337 | - | -10.19 % | $ 1.99 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
-80.1 | - | - | $ 1.77 B | USA |
 |
Avinger
AVGR
|
-0.18 | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
885 | - | - | $ 3.31 B | USA |
 |
Eargo
EAR
|
-0.145 | - | - | $ 10.2 M | USA |
 |
Lianluo Smart Limited
LLIT
|
-62.7 | - | 24.59 % | $ 44.8 M |  China |
 |
Allied Healthcare Products
AHPI
|
-1.31 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-3.31 | - | -5.86 % | $ 30.6 M | USA |
 |
ClearPoint Neuro
CLPT
|
-13.2 | $ 13.75 | 1.18 % | $ 389 M | USA |
 |
Apollo Endosurgery
APEN
|
-12.9 | - | - | $ 475 M | USA |
 |
Alphatec Holdings
ATEC
|
45.7 | $ 8.13 | -1.57 % | $ 1.22 B | USA |
 |
Aziyo Biologics
AZYO
|
-1.24 | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
-1.53 | - | 37.08 % | $ 85.7 M | USA |
 |
BIOLASE
BIOL
|
-0.0136 | - | -13.19 % | $ 166 K | USA |
 |
Conformis
CFMS
|
-0.252 | - | - | $ 16.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
-7.85 | $ 1.13 | 0.89 % | $ 19.1 M | USA |
 |
Cardiovascular Systems
CSII
|
-24.8 | - | 0.15 % | $ 844 M | USA |
 |
Helius Medical Technologies
HSDT
|
-244 | $ 1.41 | -4.73 % | $ 31.1 M | USA |
 |
CryoLife, Inc.
CRY
|
180 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
15 | $ 78.38 | 1.57 % | $ 4.28 B |  Britain |
 |
CHF Solutions, Inc.
CHFS
|
-0.0621 | - | 1.15 % | $ 34.5 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-2.82 | $ 0.41 | -2.72 % | $ 25.5 M | USA |
 |
Pulmonx Corporation
LUNG
|
-2.25 | $ 1.43 | -6.54 % | $ 58.2 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
-90 | $ 18.46 | -0.16 % | $ 433 M | USA |
 |
Delcath Systems
DCTH
|
14.5 | $ 11.19 | -4.28 % | $ 401 M | USA |
 |
Soliton, Inc.
SOLY
|
-18.5 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
-1.02 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-30.7 | - | 0.03 % | $ 1.58 B |  Israel |
 |
Misonix, Inc.
MSON
|
-6.81 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
-25 | - | - | $ 111 M |  Canada |
 |
Orthofix Medical
OFIX
|
14.7 | $ 9.73 | -1.42 % | $ 385 M |  Curacao |
 |
LENSAR
LNSR
|
-4.81 | $ 5.68 | -0.18 % | $ 67.9 M | USA |
 |
Dynatronics Corporation
DYNT
|
6.49 | - | 14.99 % | $ 929 K | USA |
 |
Electromed
ELMD
|
15.3 | $ 37.18 | 2.17 % | $ 314 M | USA |
 |
MiMedx Group
MDXG
|
10.5 | $ 3.64 | -1.89 % | $ 538 M | USA |
 |
Butterfly Network
BFLY
|
-74.5 | $ 5.39 | 5.07 % | $ 1.33 B | USA |
 |
Intersect ENT, Inc.
XENT
|
-20.1 | - | - | $ 955 M | USA |
 |
Second Sight Medical Products
EYES
|
-10.8 | - | -0.97 % | $ 54.4 M | USA |
 |
Myomo
MYO
|
-2.34 | $ 1.54 | 16.67 % | $ 64.5 M | USA |
 |
GBS
GBS
|
-0.256 | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
16.6 | $ 80.86 | -2.01 % | $ 10.9 B | USA |
 |
Insulet Corporation
PODD
|
31.9 | $ 150.71 | -5.58 % | $ 10.6 B | USA |
 |
Profound Medical Corp.
PROF
|
-4.34 | $ 6.71 | -1.61 % | $ 203 M | Canada |
 |
CONMED Corporation
CNMD
|
7.72 | $ 36.3 | -1.63 % | $ 1.13 B | USA |
 |
Inspire Medical Systems
INSP
|
15.1 | $ 42.28 | 0.17 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
15.2 | $ 91.37 | -2.9 % | $ 3.17 B | USA |
 |
Invacare Corporation
IVC
|
-0.436 | - | - | $ 24.7 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
30.6 | $ 85.98 | -1.78 % | $ 50.3 B | USA |
 |
Sintx Technologies
SINT
|
-0.806 | $ 2.07 | -2.13 % | $ 5.74 M | USA |